Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Montelukast 1%/Loratadine 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, providing targeted treatment for conditions such as Allergic Rhinitis, Asthma, Urticaria, Atopic Dermatitis, and Chronic Idiopathic Urticaria. The gel-like consistency ensures optimal absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Montelukast 1%/Loratadine 2% Topical Gel is a specially compounded medication, designed to provide targeted treatment for a variety of skin conditions. This unique formulation combines the anti-inflammatory properties of Montelukast and the antihistamine benefits of Loratadine, offering relief from symptoms such as itching, redness, and inflammation. Montelukast works by reducing swelling and irritation, while Loratadine helps to alleviate itching and redness.
The Montelukast 1%/Loratadine 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, ensuring that the active ingredients are delivered directly to the affected area. The gel-like consistency allows for smooth application and absorption, providing targeted treatment where it's needed most.
This formulation is safe for use in adults and children over the age of two. To use, simply apply a thin layer of the gel to the affected area twice daily, or as directed by a healthcare provider.
We understand the discomfort and distress that skin conditions can cause, and we strive to offer solutions that provide relief and improve quality of life. If you have any questions about this formulation, or if you need further information, please don't hesitate to reach out to us.
Montelukast 1%/Loratadine 2% Topical Gel is a compounded formulation designed for targeted treatment of allergic rhinitis, chronic idiopathic urticaria, and atopic dermatitis. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. The gel-like consistency aids in the absorption of the active ingredients, Montelukast and Loratadine.
Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, inflammatory mediators that are released during an allergic reaction. On the other hand, Loratadine is an antihistamine that inhibits the action of histamine, another inflammatory mediator released during an allergic reaction. The combined action of these two medications helps to reduce inflammation and alleviate the symptoms of allergic rhinitis, chronic idiopathic urticaria, and atopic dermatitis.
It is crucial to note that Montelukast 1%/Loratadine 2% Topical Gel should not be used by patients with known hypersensitivity to either of the active ingredients. Patients should also be advised to avoid contact with the eyes as this may cause irritation. It is recommended to use the medication as directed and not to exceed the prescribed dosage.
Patients using this topical gel should be monitored for signs of adverse reactions, such as skin irritation, rash, or hives. If any of these symptoms occur, the patient should immediately discontinue use of the medication and contact their healthcare provider.
If you have any questions or concerns about Montelukast 1%/Loratadine 2% Topical Gel, please do not hesitate to reach out for further information.
Montelukast 1%/Loratadine 2% Topical Gel is a compounded medication designed to address various skin conditions such as eczema, psoriasis, and contact dermatitis. This unique formulation combines the anti-inflammatory properties of montelukast and loratadine to effectively reduce inflammation and alleviate itching.
Montelukast functions by inhibiting the action of leukotrienes, chemicals that trigger inflammation. On the other hand, loratadine works by blocking histamine, another chemical that induces inflammation. The synergistic action of these two active ingredients helps to manage inflammation and itching associated with various skin conditions.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. This ensures targeted treatment and optimal absorption of the active ingredients. It is recommended to apply the gel to the affected skin area twice daily or as directed by your healthcare provider. Care should be taken to avoid contact with the eyes, nose, and mouth during application. In case of accidental contact, rinse thoroughly with water.
While Montelukast 1%/Loratadine 2% Topical Gel is generally well-tolerated, some individuals may experience side effects such as skin irritation, burning, or stinging. If you encounter any of these side effects, it is advisable to consult your healthcare provider immediately.
If you have any queries or concerns regarding the use of Montelukast 1%/Loratadine 2% Topical Gel, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment for your skin condition.
Montelukast 1%/Loratadine 2% Topical Gel is a compounded formulation designed for targeted treatment of various conditions. This semisolid formulation is dispensed through a pump mechanism, ensuring easy and precise application on the skin. The active ingredients in this gel-like consistency are absorbed into the skin to provide relief from symptoms associated with a range of allergic reactions.
This formulation may be used to treat allergic conjunctivitis, a condition characterized by inflammation and redness of the eyes due to allergies. Additionally, this topical gel may be used to alleviate symptoms of allergic reactions to insect bites, such as redness, swelling, and itching.
Montelukast 1%/Loratadine 2% Topical Gel may also be beneficial in reducing the severity of symptoms associated with seasonal allergies, including sneezing, runny nose, and itchy eyes. Furthermore, it may be used to alleviate symptoms of chronic urticaria, such as hives, itching, and swelling.
It's important to note that this formulation is not intended to replace other medications prescribed for these conditions. Patients should consult with their healthcare provider before starting any new medication regimen. If you have any questions about the use of Montelukast 1%/Loratadine 2% Topical Gel for any of these conditions, please consult with your healthcare provider.
This is a compounded formulation that contains 1% Montelukast and 2% Loratadine. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The active ingredients in this formulation, Montelukast and Loratadine, are absorbed through the skin to provide targeted treatment. Montelukast is a leukotriene receptor antagonist that helps reduce inflammation and bronchoconstriction, while Loratadine is an antihistamine that helps to reduce allergic reactions.
This gel should be applied to the skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
It is generally safe to use on most parts of the body, but it is always best to follow the specific instructions provided by your healthcare provider.
Side effects can vary from person to person. Some people may experience skin irritation or allergic reactions. If you experience any unusual symptoms, contact your healthcare provider immediately.
Before using this gel, you should discuss with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
Before starting any new medication, you should always inform your healthcare provider about any other medications you are currently taking, including over-the-counter drugs and supplements.
This gel should be stored at room temperature, away from heat and direct light. Do not freeze. Keep out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply extra doses.
If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
